99 related articles for article (PubMed ID: 7712463)
1. Prevalence of androgen receptor gene mutations in latent prostatic carcinomas from Japanese men.
Takahashi H; Furusato M; Allsbrook WC; Nishii H; Wakui S; Barrett JC; Boyd J
Cancer Res; 1995 Apr; 55(8):1621-4. PubMed ID: 7712463
[TBL] [Abstract][Full Text] [Related]
2. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
[TBL] [Abstract][Full Text] [Related]
3. p16 (CDKN2/MTS1) gene deletions are rare in prostatic carcinomas in the United States and Japan.
Mangold KA; Takahashi H; Brandigi C; Wada T; Wakui S; Furusato M; Boyd J; Chandler FW; Allsbrook WC
J Urol; 1997 Mar; 157(3):1117-20. PubMed ID: 9072554
[TBL] [Abstract][Full Text] [Related]
4. Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers.
Gaddipati JP; McLeod DG; Heidenberg HB; Sesterhenn IA; Finger MJ; Moul JW; Srivastava S
Cancer Res; 1994 Jun; 54(11):2861-4. PubMed ID: 8187068
[TBL] [Abstract][Full Text] [Related]
5. Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone.
Culig Z; Stober J; Gast A; Peterziel H; Hobisch A; Radmayr C; Hittmair A; Bartsch G; Cato AC; Klocker H
Cancer Detect Prev; 1996; 20(1):68-75. PubMed ID: 8907206
[TBL] [Abstract][Full Text] [Related]
6. Low incidence of androgen receptor gene mutations in human prostatic tumors using single strand conformation polymorphism analysis.
Evans BA; Harper ME; Daniells CE; Watts CE; Matenhelia S; Green J; Griffiths K
Prostate; 1996 Mar; 28(3):162-71. PubMed ID: 8628719
[TBL] [Abstract][Full Text] [Related]
7. [Mutations of the androgen receptor gene a possible role in prostate cancer].
Mowszowicz I; Mestayer C
Bull Cancer; 1997 Feb; 84(2):183-8. PubMed ID: 9180843
[TBL] [Abstract][Full Text] [Related]
8. Mutations of ras genes are relatively frequent in Japanese prostate cancers: pointing to genetic differences between populations.
Shiraishi T; Muneyuki T; Fukutome K; Ito H; Kotake T; Watanabe M; Yatani R
Anticancer Res; 1998; 18(4B):2789-92. PubMed ID: 9713462
[TBL] [Abstract][Full Text] [Related]
9. Different patterns of p53 mutations in prostatic intraepithelial neoplasia and concurrent carcinoma: analysis of microdissected specimens.
Yasunaga Y; Shin M; Fujita MQ; Nonomura N; Miki T; Okuyama A; Aozasa K
Lab Invest; 1998 Oct; 78(10):1275-9. PubMed ID: 9800953
[TBL] [Abstract][Full Text] [Related]
10. R726L androgen receptor mutation is uncommon in prostate cancer families in the united states.
Gruber SB; Chen H; Tomsho LP; Lee N; Perrone EE; Cooney KA
Prostate; 2003 Mar; 54(4):306-9. PubMed ID: 12539229
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas.
Machado JC; Soares P; Carneiro F; Rocha A; Beck S; Blin N; Berx G; Sobrinho-Simões M
Lab Invest; 1999 Apr; 79(4):459-65. PubMed ID: 10211998
[TBL] [Abstract][Full Text] [Related]
12. Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy.
Hongyo T; Buzard GS; Palli D; Weghorst CM; Amorosi A; Galli M; Caporaso NE; Fraumeni JF; Rice JM
Cancer Res; 1995 Jun; 55(12):2665-72. PubMed ID: 7780983
[TBL] [Abstract][Full Text] [Related]
13. Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms.
Tarmin L; Yin J; Harpaz N; Kozam M; Noordzij J; Antonio LB; Jiang HY; Chan O; Cymes K; Meltzer SJ
Cancer Res; 1995 May; 55(10):2035-8. PubMed ID: 7743497
[TBL] [Abstract][Full Text] [Related]
14. Point mutations of the c-Ki-ras gene in carcinoma and atypical epithelium associated with congenital biliary dilation.
Tomono H; Nimura Y; Aono K; Nakashima I; Iwamoto T; Nakashima N
Am J Gastroenterol; 1996 Jun; 91(6):1211-4. PubMed ID: 8651173
[TBL] [Abstract][Full Text] [Related]
15. p53 immunohistochemical and genetic alterations are associated at high incidence with post-irradiated locally persistent prostate carcinoma.
Prendergast NJ; Atkins MR; Schatte EC; Paulson DF; Walther PJ
J Urol; 1996 May; 155(5):1685-92. PubMed ID: 8627854
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence.
Tilley WD; Buchanan G; Hickey TE; Bentel JM
Clin Cancer Res; 1996 Feb; 2(2):277-85. PubMed ID: 9816170
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of human androgen receptor (hAR) gene in prostate cancer cell lines PC-EW and PC-OR.
Engehausen DG; Krause FS; Fleischmann J; Akcetin Z; Schrott KM; Endele S
Anticancer Res; 2005; 25(3A):1611-4. PubMed ID: 16033069
[TBL] [Abstract][Full Text] [Related]
18. Mutation screening of the androgen receptor promoter and untranslated regions in prostate cancer.
Waltering KK; Wallén MJ; Tammela TL; Vessella RL; Visakorpi T
Prostate; 2006 Nov; 66(15):1585-91. PubMed ID: 16927275
[TBL] [Abstract][Full Text] [Related]
19. Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran.
Sepehr A; Tanière P; Martel-Planche G; Zia'ee AA; Rastgar-Jazii F; Yazdanbod M; Etemad-Moghadam G; Kamangar F; Saidi F; Hainaut P
Oncogene; 2001 Nov; 20(50):7368-74. PubMed ID: 11704866
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor gene mutations in hormone-refractory prostate cancer.
Wallén MJ; Linja M; Kaartinen K; Schleutker J; Visakorpi T
J Pathol; 1999 Dec; 189(4):559-63. PubMed ID: 10629558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
